| |
DOG Congress Home
Invitation
Organization, Deadlines
Overview of the Congress
Scientific Programme
Opening Ceremony
Ceremony 150 Years of DOG
Thursday, 20.September
Friday, 21.September
Saturday, 22.September
Sunday, 23.September
Poster Sessions
Symposia
Courses
Satellite Programme
Information
Social Programme
Sponsors, Exhibitors
DOG Homepage
|
|
AbstractSA.16.03 Specific excimer laser for glaucoma surgery ab externo Takhchidi K. P., Ereskin N. N., Doga A. V., Vartapetov S. K. S. Fyodorov Eye Microsurgery Complex, Moscow, Russia Objective: To evaluate the safety and efficacy of a specific 193 nm photopolishing scanning excimer laser for glaucoma surgery. Methods: 186 eyes of patients aged from 18 to 88 years were operated on between March 2000 and March 2006. The majority of patients had advanced and far-advanced stages of open-angle and narrow-angle glaucoma. Laser iridotomy was performed in patients with narrow-angle glaucoma to enlarge the profile of the anterior chamber angle. A 193 nm photopolishing scanning excimer-laser was used to achieve a deep non-penetrating laser trabeculo-dissection under a scleral flap through the Schlemms canal and the juxtacanalicular trabecular meshwork. Intraocular pressure (IOP) was recorded preoperatively and postoperatively at 1, 7, 14 days, at 1, 3, 6 months and thereafter every 6 months. Results: As a result of a micro-invasive intrastromal excimer laser surgery normalization of the IOP was achieved in all cases independently of the disease stage. The mean IOP was 10±2 mm Hg in the early postoperative period. No cases of hemorrhagic complications were observed. In 8% of the cases in patients with far-advanced glaucoma the descemeto-gonio-puncture (DGP) was performed in excimer laser intervention area. It allowed restoring aqueous humor outflow pathways and normalizing the IOP. In the long-term follow-up the mean IOP was 17 mm Hg. In 1 year post-op and more a development of a cystic filtering bleb was observed in 2 eyes. A monotherapy with 0.5% Betoptic solution instillations two times per day was administered in 18 patients with far-advanced glaucoma (10% of cases). Conclusions: Creation of a specialized excimer laser allows us to develop a safe technology of glaucoma treatment compared to traditional incision surgery.
|
|